BACE-Inhibitor successfully tested in Alzheimer's animal model

by Technical University MunichMarc Aurel Busche at the two-photon microscope, which allows to visualize nerve cells with high temporal and spatial resolution in the intact brain. Credit: Kurt Bau

Updated on: March 19,2024

BACE-Inhibitor successfully tested in Alzheimer's animal model

by Technical University MunichMarc Aurel Busche at the two-photon microscope, which allows to visualize nerve cells with high temporal and spatial resolution in the intact brain. Credit: Kurt Bau

Updated on:March 19,2024

Microscopic blood vessel disease in the brain's white matter associated with worse cognition in Alzheimer's

by Medical College of Georgia at Augusta UniversityDr. Zsolt Bagi with coauthors Katie Anne Fopiano, AU graduate student, and Dr. Yanna Tian, who just earned her graduate degree from AU and has s

Updated on: April 20,2024

Microscopic blood vessel disease in the brain's white matter associated with worse cognition in Alzheimer's

by Medical College of Georgia at Augusta UniversityDr. Zsolt Bagi with coauthors Katie Anne Fopiano, AU graduate student, and Dr. Yanna Tian, who just earned her graduate degree from AU and has s

Updated on:April 20,2024

Alzheimer's treatment shows unique results

by Uppsala UniversityDespite his team’s successes, Lars Lannfelt does not want to speculate on when an approved treatment can be available for health care. Credit: Johan WahlgrenIn late July ther

Updated on: April 08,2024

Alzheimer's treatment shows unique results

by Uppsala UniversityDespite his team’s successes, Lars Lannfelt does not want to speculate on when an approved treatment can be available for health care. Credit: Johan WahlgrenIn late July ther

Updated on:April 08,2024

Dementia: Blood levels could point to early loss of neuronal connections

by Marcus Neitzert,German Center for Neurodegenerative DiseasesGroup comparisons, correlation analyses, and diagnostic performance of serum beta-synuclein and plasma pTau181. (A) Serum beta-synu

Updated on: May 06,2024

Dementia: Blood levels could point to early loss of neuronal connections

by Marcus Neitzert,German Center for Neurodegenerative DiseasesGroup comparisons, correlation analyses, and diagnostic performance of serum beta-synuclein and plasma pTau181. (A) Serum beta-synu

Updated on:May 06,2024

Estrogen replacement may protect against Alzheimer's disease in women

by IOS PressCredit: CC0 Public DomainAlzheimer's disease (AD) is the most common neurodegenerative disease and the leading cause of dementia. It affects more women than men. A new study publi

Updated on: May 13,2024

Estrogen replacement may protect against Alzheimer's disease in women

by IOS PressCredit: CC0 Public DomainAlzheimer's disease (AD) is the most common neurodegenerative disease and the leading cause of dementia. It affects more women than men. A new study publi

Updated on:May 13,2024

Tardive dyskinesia impacts patients and caregivers

by Lori SolomonTardive dyskinesia (TD) poses a substantial burden for both caregivers and patients, according to a study published online Nov. 28 in theJournal of Patient-Reported Outcomes.Rakes

Updated on: February 03,2024

Tardive dyskinesia impacts patients and caregivers

by Lori SolomonTardive dyskinesia (TD) poses a substantial burden for both caregivers and patients, according to a study published online Nov. 28 in theJournal of Patient-Reported Outcomes.Rakes

Updated on:February 03,2024

Alzheimer's linked to the brain's 'garbage disposal service'

by Andrew Spence, The LeadPET scan of a human brain with Alzheimer's disease. Credit: public domainResearchers in South Australia have found a genetic link between Alzheimer's disease and the

Updated on: April 25,2024

Alzheimer's linked to the brain's 'garbage disposal service'

by Andrew Spence, The LeadPET scan of a human brain with Alzheimer's disease. Credit: public domainResearchers in South Australia have found a genetic link between Alzheimer's disease and the

Updated on:April 25,2024

Successful Phase 2 clinical trial for neflamapimod in mild-to-moderate Lewy body dementia

by University of North Carolina at Chapel Hill School of MedicineCredit: CC0 Public DomainEIP Pharma announced on October 6 that a phase 2 study in patients with mild-to-moderate Lewy body dement

Updated on: April 01,2024

Successful Phase 2 clinical trial for neflamapimod in mild-to-moderate Lewy body dementia

by University of North Carolina at Chapel Hill School of MedicineCredit: CC0 Public DomainEIP Pharma announced on October 6 that a phase 2 study in patients with mild-to-moderate Lewy body dement

Updated on:April 01,2024

Antibody therapy inspired by patient case reduces tau tangles in a preclinical model of Alzheimer's disease

by Mass General BrighamCredit: Pixabay/Pete Linforth.A team led by researchers from Mass General Brigham reports promising results for a monoclonal antibody that takes aim at a new target for Alz

Updated on: March 02,2024

Antibody therapy inspired by patient case reduces tau tangles in a preclinical model of Alzheimer's disease

by Mass General BrighamCredit: Pixabay/Pete Linforth.A team led by researchers from Mass General Brigham reports promising results for a monoclonal antibody that takes aim at a new target for Alz

Updated on:March 02,2024

Expert offers perspective on experimental Alzheimer's disease drug

by Deb BalzerCredit: Pixabay/CC0 Public DomainAccording to drugmakers Eisai and Biogen, a Phase 3 clinical study on a potential new Alzheimer's disease drug shows promise. The study findings show

Updated on: April 18,2024

Expert offers perspective on experimental Alzheimer's disease drug

by Deb BalzerCredit: Pixabay/CC0 Public DomainAccording to drugmakers Eisai and Biogen, a Phase 3 clinical study on a potential new Alzheimer's disease drug shows promise. The study findings show

Updated on:April 18,2024

A million Aussies will have dementia by 2056, so now is the time to act on prevention

by Cate Swannell, Medical Journal of AustraliaCredit: CC0 Public DomainDementia prevention needs to be Australia's next public health area of focus, as the nation heads towards a projected number

Updated on: May 20,2024

A million Aussies will have dementia by 2056, so now is the time to act on prevention

by Cate Swannell, Medical Journal of AustraliaCredit: CC0 Public DomainDementia prevention needs to be Australia's next public health area of focus, as the nation heads towards a projected number

Updated on:May 20,2024

Artificial Intelligence helps early detection of dementia

by EurostarsCredit: EurostarsThrough pioneering algorithmic analysis, the Eurostars project BRAINIQ has developed software that uses artificial intelligence to detect the signs and progression of deme

Updated on: March 09,2024

Artificial Intelligence helps early detection of dementia

by EurostarsCredit: EurostarsThrough pioneering algorithmic analysis, the Eurostars project BRAINIQ has developed software that uses artificial intelligence to detect the signs and progression of deme

Updated on:March 09,2024